Integral Diagnostics Balance Sheet Health
Financial Health criteria checks 2/6
Integral Diagnostics has a total shareholder equity of A$300.4M and total debt of A$220.3M, which brings its debt-to-equity ratio to 73.3%. Its total assets and total liabilities are A$745.8M and A$445.4M respectively. Integral Diagnostics's EBIT is A$42.4M making its interest coverage ratio 2.1. It has cash and short-term investments of A$18.0M.
Key information
73.3%
Debt to equity ratio
AU$220.28m
Debt
Interest coverage ratio | 2.1x |
Cash | AU$17.99m |
Equity | AU$300.38m |
Total liabilities | AU$445.42m |
Total assets | AU$745.80m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ITGD.F's short term assets (A$65.7M) do not cover its short term liabilities (A$86.1M).
Long Term Liabilities: ITGD.F's short term assets (A$65.7M) do not cover its long term liabilities (A$359.4M).
Debt to Equity History and Analysis
Debt Level: ITGD.F's net debt to equity ratio (67.3%) is considered high.
Reducing Debt: ITGD.F's debt to equity ratio has reduced from 99.1% to 73.3% over the past 5 years.
Debt Coverage: ITGD.F's debt is well covered by operating cash flow (28.2%).
Interest Coverage: ITGD.F's interest payments on its debt are not well covered by EBIT (2.1x coverage).